Skip Navigation


NDT Plus Advance Access originally published online on September 1, 2008
NDT Plus 2008 1(6):414-416; doi:10.1093/ndtplus/sfn144
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
1/6/414    most recent
sfn144v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Hoshino, J.
Right arrow Articles by Takaichi, K.
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2008]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Pathologic improvement after high-dose melphalan and autologous stem cell transplantation for primary systemic amyloidosis

Junichi Hoshino1, Yoshifumi Ubara1, Kenichi Ohashi2, Fumi Takemoto1 and Kenmei Takaichi1

1 Nephrology Center
2 Department of Pathology, Toranomon Hospital, Tokyo, Japan

Correspondence: Correspondence and offprint requests to: Junichi Hoshino, 2-2-2 Toranomon, Minato-ku, Tokyo 105-8470, Japan. Tel: +81-3-3588-1111; Fax: +81-3-3560-7785; E-mail: hoshino{at}toranomon.gr.jp


  Abstract

Although primary systemic amyloid light-chain amyloidosis was considered intractable, recent advances in therapy have been reported to result in better clinical outcomes including remission of nephrotic syndrome. However, changes in renal pathologic findings after high-dose chemo- therapy have not been characterized. We describe a patient who underwent serial renal biopsies and had complete remission after high-dose melphalan and autologous stem cell transplantation for this form of amyloidosis. Successive renal biopsy specimens showed reduction in amyloid staining mainly in interlobular arterial and arteriolar walls. Thus, amyloid light-chain amyloidosis resolved both clinically and pathologically after high-dose chemotherapy.

Key Words: AL amyloidosis • autologous stem cell transplantation • high-dose melphalan • pathologic improvement

Received for publication July 4, 2008. Accepted for publication August 7, 2008.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.